Below are the most recent publications written about "Botulinum Toxins, Type A" by people in Profiles.
-
Zorowitz RD, Jacinto J, Ashford S, Beneteau M, Maisonobe P, Hannes C, Esquenazi A. Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice. J Rehabil Med. 2025 Feb 07; 57:jrm42605.
-
Holubyeva A, Khin K, Gao T, Adair S, Wasenda E, Dhariwal L, Caraballo R, Lozo S, Rutledge J, Botros C. Onabotulinum Toxin A-Led Urinary Tract Infections-Should we Safeguard? A Randomized Controlled Trial. Int Urogynecol J. 2025 Feb; 36(2):469-474.
-
Esquenazi A, Zorowitz RD, Ashford S, Beneteau M, Maisonobe P, Hannes C, Jacinto J. Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study. Arch Phys Med Rehabil. 2025 06; 106(6):894-901.
-
Gollomp SM, Khalifian S, Gokhale S. Mitigating Immunogenicity by Coordinating Botulinum Toxin Treatments Between Aesthetics and Therapeutics. Dermatol Surg. 2024 09 01; 50(9S):S35-S37.
-
Heckert K, Biering-S?rensen B, B?umer T, Khan O, Pagan F, Paulin M, Stitik T, Verduzco-Gutierrez M, Reebye R. Delphi Analysis: Optimizing Anatomy Teaching and Ultrasound Training for Botulinum Neurotoxin Type A Injection in Spasticity and Dystonia. Toxins (Basel). 2024 08 21; 16(8).
-
Pozo-Rosich P, Alpuente A, Silberstein SD, Burstein R. Insights from 25?years of onabotulinumtoxinA in migraine - mechanisms and management. Nat Rev Neurol. 2024 09; 20(9):555-568.
-
Silberstein SD, Diener HC, Dodick DW, Sommer K, Lipton RB. Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials. Headache. 2024 Jul-Aug; 64(7):838-848.
-
Bavikatte G, Francisco GE, Jost WH, Baricich A, Duarte E, Tang SFT, Schwartz M, Nelson M, Musacchio T, Esquenazi A. Pain, disability, and quality of life in participants after concurrent onabotulinumtoxinA treatment of upper and lower limb spasticity: Observational results from the ASPIRE study. PM R. 2024 Nov; 16(11):1175-1189.
-
Piccini JP, Ahlsson A, Dorian P, Gillinov AM, Kowey PR, Mack MJ, Milano CA, Noiseux N, Perrault LP, Ryan W, Steinberg JS, Voisine P, Waldron NH, Gleason KJ, Titanji W, Leaback RD, O'Sullivan A, Ferguson WG, Benussi S. Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation. JACC Clin Electrophysiol. 2024 May; 10(5):930-940.
-
Clague MD, Goodman G, Taing C, Stuart L, Orsatti ML, Holbrook J, Delaney J, Mackay B. Hyperdiluted Botulinum Toxin and Intense Pulsed Light Treatment: A Case Series to Illustrate a Novel Protocol for Hypertrophic Scar Reduction. Plast Aesthet Nurs (Phila). 2024 Apr-Jun 01; 44(2):116-123.